639 Management of immune-related adverse events in patients with primary advanced or recurrent endometrial cancer: dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial

Zoltán Novák,Michael A Gold, Jørn Herrstedt, Sarah Gill,Antonella Savarese, John Diaz,Stefan Kommoss, Guilherme Cantuaria, Ingrid Boere, Evelyn Fleming,Lucy Gilbert, Kathryn Pennington,Robert Holloway, Eirwen M Miller,Rachel Miller,Matthew A Powell, Christine Dabrowski, Shadi Stevens,Mansoor Raza Mirza,Carolyn Mccourt

Oral Sessions(2024)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要